Discontinuation of immunomodulator therapy in infliximab-treated children with Crohn disease; one year outcome evaluating influences on disease activity and infliximab antibody formation Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 2008
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Inflammatory Bowel Diseases Journal